Chronic kidney disease undergoing hemodialysis treatment
Conditions
Interventions
None listed
Sponsors
Division of Blood Purification Therapy, Niigata University Medical and Dental Hospital
Kureha Corporation
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Chronic kidney disease patients undergoing hemodilysis treatment 2. Participants provided written informed consent
Exclusion criteria
Exclusion criteria: 1. Participants who do not recieve hemodialysis treatment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Association of protein-bound uremic toxins, such as indoxyl sulfate, p-cresyl sulfate and phenyl sulfate, with degree of pruritus from visual analog scale and 5D itch scale. | — |
Secondary
| Measure | Time frame |
|---|---|
| Association of protein-bound uremic toxins, such as indoxyl sulfate, p-cresyl sulfate and phenyl sulfate, with quality of life score using KDQOL. All cause mortality, hospitalization owing to cardiovascular event and infection during two year observation. | — |
Countries
Japan
Contacts
Public ContactSuguru Yamamoto
Niigata University Medical and Dental Hospital Division of Blood Purification Therapy
Outcome results
None listed